{
  "company_number": "11034700",
  "name": "Mibe Pharma UK Ltd",
  "url": "/company/11034700",
  "status": "active",
  "is_active": true,
  "company_type": "ltd",
  "incorporated_on": "2017-10-27",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "46460",
      "description": "Wholesale of pharmaceutical goods",
      "section": "G",
      "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles",
      "url": "/sic/46460"
    },
    {
      "code": "47749",
      "description": "Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c.",
      "section": "G",
      "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles",
      "url": "/sic/47749"
    }
  ],
  "registered_address": {
    "id": 734555,
    "url": "/address/734555",
    "line1": "4 COLEMAN STREET",
    "line2": "6TH FLOOR",
    "post_town": "LONDON",
    "county": "",
    "country": "ENGLAND",
    "postcode": "EC2R 5AR"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11034700",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2026-09-30",
    "last_made_up": "2024-12-31",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/11034700/accounts/2024-12-31",
        "made_up_date": "2024-12-31",
        "period_start": "2024-12-31",
        "period_end": "2024-12-31",
        "entity_name": "Mibe Pharma UK Ltd",
        "dormant": false,
        "average_employees": "0.00",
        "tangible_fixed_assets": null,
        "debtors": "17198.00",
        "cash_bank_in_hand": "17843.00",
        "current_assets": "35041.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "33082.00",
        "total_assets_less_current_liabilities": "197735.00",
        "net_assets_liabilities": "-2631503.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2025.zip"
      },
      {
        "url": "/company/11034700/accounts/2023-12-31",
        "made_up_date": "2023-12-31",
        "period_start": "2023-12-31",
        "period_end": "2023-12-31",
        "entity_name": "Mibe Pharma UK Ltd",
        "dormant": false,
        "average_employees": "6.00",
        "tangible_fixed_assets": null,
        "debtors": "201039.00",
        "cash_bank_in_hand": "37015.00",
        "current_assets": "238054.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "192512.00",
        "total_assets_less_current_liabilities": "373605.00",
        "net_assets_liabilities": "-2527033.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2024.zip"
      },
      {
        "url": "/company/11034700/accounts/2022-12-31",
        "made_up_date": "2022-12-31",
        "period_start": "2022-12-31",
        "period_end": "2022-12-31",
        "entity_name": "Mibe Pharma UK Ltd",
        "dormant": false,
        "average_employees": "8.00",
        "tangible_fixed_assets": "197533.00",
        "debtors": "292149.00",
        "cash_bank_in_hand": "516794.00",
        "current_assets": "808943.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "776748.00",
        "total_assets_less_current_liabilities": "974281.00",
        "net_assets_liabilities": "-2893907.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2023.zip"
      },
      {
        "url": "/company/11034700/accounts/2021-12-31",
        "made_up_date": "2021-12-31",
        "period_start": "2021-12-31",
        "period_end": "2021-12-31",
        "entity_name": "Mibe Pharma UK Ltd",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "220431.00",
        "debtors": "249038.00",
        "cash_bank_in_hand": "82904.00",
        "current_assets": "835511.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "730980.00",
        "total_assets_less_current_liabilities": "951411.00",
        "net_assets_liabilities": "-1612060.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2022.zip"
      },
      {
        "url": "/company/11034700/accounts/2020-12-31",
        "made_up_date": "2020-12-31",
        "period_start": "2020-12-31",
        "period_end": "2020-12-31",
        "entity_name": "Mibe Pharma UK Ltd",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "237605.00",
        "debtors": "87861.00",
        "cash_bank_in_hand": "644812.00",
        "current_assets": "959908.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "780746.00",
        "total_assets_less_current_liabilities": "1018351.00",
        "net_assets_liabilities": "-953863.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2021.zip"
      },
      {
        "url": "/company/11034700/accounts/2019-12-31",
        "made_up_date": "2019-12-31",
        "period_start": "2019-12-31",
        "period_end": "2019-12-31",
        "entity_name": "Mibe Pharma UK Ltd",
        "dormant": false,
        "average_employees": "2.00",
        "tangible_fixed_assets": "126714.00",
        "debtors": "70751.00",
        "cash_bank_in_hand": "234762.00",
        "current_assets": "574975.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-906987.00",
        "total_assets_less_current_liabilities": "-780273.00",
        "net_assets_liabilities": "-780344.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2020.zip"
      },
      {
        "url": "/company/11034700/accounts/2018-12-31",
        "made_up_date": "2018-12-31",
        "period_start": "2018-12-31",
        "period_end": "2018-12-31",
        "entity_name": "Mibe Pharma UK Ltd",
        "dormant": false,
        "average_employees": "2.00",
        "tangible_fixed_assets": "520.00",
        "debtors": "73391.00",
        "cash_bank_in_hand": "55780.00",
        "current_assets": "144964.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-254326.00",
        "total_assets_less_current_liabilities": "-253806.00",
        "net_assets_liabilities": "-253905.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-July2019.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/11034700/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2026-09-01",
    "last_made_up": "2025-08-18"
  },
  "officers": [],
  "psc": [
    {
      "name": "Wilhelm Beier",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/5223146",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent",
        "voting-rights-75-to-100-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2017-10-27",
      "ceased_on": "2026-07-31",
      "nationality": "German",
      "country_of_residence": "Germany",
      "source": "snapshot"
    },
    {
      "name": "Dermapharm Ag",
      "kind": "corporate-entity-person-with-significant-control",
      "person_url": null,
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent",
        "voting-rights-75-to-100-percent"
      ],
      "notified_on": "2026-08-01",
      "ceased_on": null,
      "nationality": "",
      "country_of_residence": "",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "stream",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-07T13:47:05+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}